Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...
The list below includes contraindications of ... are both used to treat major depressive disorder (depression). These drugs have many of the same interactions. It’s also important to note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback